|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.280 USD | -2.67% |
|
-0.27% | +267.68% |
| 04-09 | ImmunityBio, Inc. Reports Preliminary Revenue Results for the First Quarter Ended March 31, 2026 | CI |
| 04-09 | ImmunityBio Reports Preliminary Q1 Net Product Revenue | MT |
| Capitalization | 7.52B 6.4B 5.93B 5.58B 10.4B 699B 10.61B 69.54B 27.21B 336B 28.21B 27.62B 1,196B | P/E ratio 2026 * |
-28.2x | P/E ratio 2027 * | -126x |
|---|---|---|---|---|---|
| Enterprise value | 7.52B 6.4B 5.93B 5.58B 10.4B 699B 10.61B 69.54B 27.21B 336B 28.21B 27.62B 1,196B | EV / Sales 2026 * |
35.9x | EV / Sales 2027 * | 15.5x |
| Free-Float |
21.9% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ImmunityBio, Inc.
| 1 day | -2.67% | ||
| 1 week | -0.27% | ||
| Current month | -5.08% | ||
| 1 month | -6.91% | ||
| 3 months | +181.08% | ||
| 6 months | +208.47% | ||
| Current year | +267.68% |
| 1 week | 6.68 |  | 7.64 |
| 1 month | 6.54 | | 9.54 |
| Current year | 1.98 | | 12.43 |
| 1 year | 1.83 | | 12.43 |
| 3 years | 1.25 | | 12.43 |
| 5 years | 1.21 | | 19.72 |
| 10 years | 1.21 | | 40.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 57 | 30/09/2020 |
| Chief Executive Officer | 73 | 28/02/2015 | |
David Sachs
DFI | Director of Finance/CFO | 48 | 28/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 71 | 28/02/2021 | |
| Chairman | 73 | 30/11/2014 | |
Richard Adcock
BRD | Director/Board Member | 57 | 28/03/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.67% | -0.27% | +176.81% | +375.82% | 7.52B | |
| +0.80% | +5.38% | +33.62% | +98.60% | 49.79B | |
| +0.13% | +6.34% | +104.09% | +28.22% | 46.97B | |
| -3.00% | -4.69% | +125.77% | +831.47% | 33.42B | |
| +3.83% | +4.74% | -1.06% | -24.09% | 24.15B | |
| -1.73% | +0.28% | +66.42% | -34.48% | 18.97B | |
| -0.69% | +1.79% | +46.12% | -32.61% | 17.25B | |
| -0.07% | +0.44% | +58.83% | +196.35% | 16.25B | |
| +1.86% | +1.50% | -15.36% | +1,169.03% | 15.25B | |
| -2.31% | -1.11% | +50.03% | - | 14.68B | |
| Average | -0.38% | +1.37% | +64.53% | +289.81% | 24.42B | |
| Weighted average by Cap. | -0.14% | +2.32% | +63.79% | +244.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 209M 178M 165M 155M 290M 19.48B 296M 1.94B 758M 9.35B 786M 769M 33.33B | 484M 412M 382M 359M 669M 45.03B 683M 4.48B 1.75B 21.62B 1.82B 1.78B 77.05B |
| Net income | -256M -218M -202M -190M -354M -23.82B -361M -2.37B -927M -11.44B -961M -941M -40.75B | -60.16M -51.25M -47.43M -44.66M -83.18M -5.6B -84.89M -556M -218M -2.69B -226M -221M -9.57B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/04/26 | 7.280 $ | -2.67% | 14,361,221 |
| 09/04/26 | 7.480 $ | +7.16% | 21,588,055 |
| 08/04/26 | 6.980 $ | +1.75% | 16,541,531 |
| 07/04/26 | 6.860 $ | -3.11% | 12,979,132 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IBRX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition